Stay updated on Magrolimab Combos in Myeloid Malignancies Clinical Trial
Sign up to get notified when there's something new on the Magrolimab Combos in Myeloid Malignancies Clinical Trial page.

Latest updates to the Magrolimab Combos in Myeloid Malignancies Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.3%
- Check27 days agoNo Change Detected
- Check35 days agoChange DetectedThe page has been updated to reflect a new version, changing from v2.14.4 to v2.15.0.SummaryDifference1.0%
- Check42 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to March 20, 2025.SummaryDifference0.7%
- Check56 days agoChange DetectedThe study has been terminated, and the sponsor has made a decision to end it. The results are now posted, indicating a significant update in the study's status.SummaryDifference2%
- Check78 days agoChange DetectedThe page now indicates that results have been submitted, replacing the previous message that no results were posted.SummaryDifference0.5%
- Check85 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference5%
Stay in the know with updates to Magrolimab Combos in Myeloid Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Magrolimab Combos in Myeloid Malignancies Clinical Trial page.